Treatment of Renal Cell Carcinoma: T2 Tumour Over 7 cm Limited to the Kidney, Not Amenable to Partial Nephrectomy

This protocol addresses surgical management of renal cell carcinoma presenting as a T2 localised mass — greater than 7 cm, confined to the kidney — in patients for whom nephron-sparing surgery is not technically feasible.

Clinical scenario

T2 tumour exceeding 7 cm in greatest dimension, limited to the kidney. The mass is localised but not treatable by partial nephrectomy. Individual patient factors — including renal function and anatomy — determine the specific surgical pathway.

Treatment approach (partial overview)

Minimally invasive surgical resection is the primary approach for eligible patients. Alternative nephron-sparing options may be considered in specific clinical circumstances. Full selection criteria, procedural guidance, and individualised decision points are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

T2 Tumour > 7 cm in greatest dimension, limited to the kidney.

Offer laparoscopic or robotic radical nephrectomy (RN) to patients with T2 tumours and localised masses not treatable by partial nephrectomy (PN).

Offer PN to patients with T2 tumours and a solitary kidney or chronic kidney disease, if technically feasible.

View source ↗